Outlook Therapeutics Inc (OTLK)
7.06
-0.16
(-2.22%)
USD |
NASDAQ |
May 31, 16:00
7.04
-0.02
(-0.28%)
After-Hours: 20:00
Outlook Therapeutics Cash from Operations (Quarterly): -19.27M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -19.27M |
December 31, 2023 | -13.03M |
September 30, 2023 | -12.74M |
June 30, 2023 | -13.22M |
March 31, 2023 | -8.115M |
December 31, 2022 | -8.901M |
September 30, 2022 | -10.25M |
June 30, 2022 | -21.10M |
March 31, 2022 | -14.33M |
December 31, 2021 | -10.99M |
September 30, 2021 | -8.990M |
June 30, 2021 | -20.19M |
March 31, 2021 | -11.75M |
December 31, 2020 | -13.32M |
September 30, 2020 | -12.08M |
June 30, 2020 | -5.956M |
March 31, 2020 | -7.083M |
December 31, 2019 | -6.674M |
September 30, 2019 | -5.942M |
Date | Value |
---|---|
June 30, 2019 | -10.31M |
March 31, 2019 | -6.259M |
December 31, 2018 | -9.781M |
September 30, 2018 | -8.394M |
June 30, 2018 | -8.535M |
March 31, 2018 | -7.439M |
December 31, 2017 | -8.671M |
September 30, 2017 | 0.0799M |
June 30, 2017 | -5.633M |
March 31, 2017 | -4.110M |
December 31, 2016 | -5.842M |
September 30, 2016 | -10.37M |
June 30, 2016 | -16.04M |
March 31, 2016 | -7.058M |
December 31, 2015 | -12.01M |
September 30, 2015 | -11.01M |
June 30, 2015 | -10.04M |
March 31, 2015 | -2.760M |
December 31, 2014 | -3.666M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-21.10M
Minimum
Jun 2022
-5.942M
Maximum
Sep 2019
-11.71M
Average
-11.37M
Median
Cash from Operations (Quarterly) Benchmarks
Cutera Inc | -37.63M |
GT Biopharma Inc | -4.163M |
Actinium Pharmaceuticals Inc | -7.374M |
Marinus Pharmaceuticals Inc | -37.46M |
Ocugen Inc | -10.60M |
Cash from Operations (Quarterly) Related Metrics
Cash from Financing (Quarterly) | 56.14M |
Free Cash Flow | -58.26M |
Free Cash Flow Per Share (Quarterly) | -1.350 |
Free Cash Flow Yield | -62.12% |